Scientists expose volunteers to flu to build better vaccines
NCT ID NCT06613737
First seen Apr 25, 2026 · Last updated Apr 30, 2026 · Updated 1 time
Summary
This study tested different doses of a new H3N2 flu virus in healthy adults aged 18 to 55. The goal was to find a safe dose that reliably causes mild flu symptoms, so future vaccines can be tested. 33 volunteers participated, and researchers monitored side effects and infection rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A H3N2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
hVIVO Services Ltd, 40 Bank Street
London, E14 5NR, United Kingdom
Conditions
Explore the condition pages connected to this study.